Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-22,551
Closed -$205K 2299
2025
Q3
$205K Buy
22,551
+202
+0.9% +$2.52K ﹤0.01% 1954
2025
Q2
$342K Buy
22,349
+2,987
+15% +$50.3K ﹤0.01% 1559
2025
Q1
$386K Buy
19,362
+11,899
+159% +$330K ﹤0.01% 1270
2024
Q4
$245K Buy
+7,463
New +$204K ﹤0.01% 1438

Other funds holding DAVA

&Partners's DAVA Position: Q4 2025 in Review

&Partners sold out of Endava (DAVA) in Q4 2025, closing a stake of 22,551 shares — an estimated $205K sold.

&Partners first reported a position in DAVA in Q4 2024 and held it in 4 quarters. The position peaked at $386K in Q1 2025. 101 funds tracked by Wall St. Rank hold DAVA as of Q4 2025.

  • &Partners reported no remaining Endava position as of Q4 2025 after selling out during the quarter.
  • &Partners sold 22,551 Endava shares in Q4 2025, an estimated $205K.
  • &Partners first reported a position in Endava in Q4 2024 and held it in 4 quarters.
  • &Partners's Endava position peaked at $386K in Q1 2025.
  • 101 funds tracked by Wall St. Rank held Endava as of Q4 2025.

Based on &Partners's 13F filing for Q4 2025, filed 17 Feb 2026.